Daily Stock List
N-Viro International Corp. (NVIC)
StockOodles and OTC Stock Review reported on N-Viro International Corp. (NVIC), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
Based in Toledo, Ohio, N-Viro International Corp. is a leader in the conversion of organic materials generated from industrial, agricultural and municipal sources. It integrates advanced technology with 21st-century design for successful commercial application of its alternative energy product called N-Viro Fuel™. N-Viro International lists on the OTCQB.
The Company combines its proprietary, patented technologies, inventive services, and materials handling expertise to provide turnkey solutions in soil enrichment and alternative fuel development. The N-Viro patented technology involves mixing a bioorganic material with alkaline reagents that prepare the bioorganic for a chemical conversion.
N-Viro Fuel™ is produced from bioorganic waste. It provides coal-fired power plants a renewable energy product. N-Viro Fuel™ is an emission control strategy; liberated ammonia helps in NOx removal. In addition, N-Viro Fuel™ is easily mixed with coal; is a Btu biomass-derived fuel; and equipment retrofits are minimal. Moreover, it uses the selective and pre-tested fly ash as an alkaline additive. It can use waste heat from the power plant to the fuel system.
Furthermore, N-Viro International has its N-Viro Soil™, which is a lime substitute. It is used as a soil amendment, lime substitute, landfill cover, and land reclamation in the U.S., the UK, Israel, Australia and Canada. N-Viro Soil™ improves texture and water-holding capacity in soil to promote root growth.
N-Viro International announced in October 2015 that N-Viro Energy (Hong Kong) Ltd. entered into a three party Memorandum of Understanding (MOU) for Business Cooperation with the Yangtze Delta Region Institute of Tsinghua University, Zhejiang and the Administrative Committee of Jiaxing Science City of the Nanhu District in Jiaxing, China. The agreement outlines a strategy for the three parties to promote technological innovation utilizing the N-Viro collection of technologies to establish a feasible and environmentally sustainable waste-to-electrical energy generation solution.
The three parties agreed to establish the N-Viro China headquarters within Jiaxing Science City. This headquarters will use the talents and technical support services of Tsinghua University to create a research organization to explore and incubate the expansion of the N-Viro waste conversion process to include other organic waste feed stocks and expand its energy generating capabilities. Tsinghua University is one of nine Chinese government chosen universities, which form the elite C9 League of universities. The intention is to co-develop and use each party's complementary advantages.
In essence, the alternative energy technology benefits of the N-Viro Technology include physical stabilization; odor control; ignitability control; pathogens destruction; and it is safely utilized.
N-Viro International Corp. (NVIC), closed Tuesday's trading session at $0.805, up 7.33%, on 17,170 volume with 17 trades. The average volume for the last 60 days is 14,112 and the stock's 52-week low/high is $0.71/$2.65.
CytoDyn, Inc. (CYDY)
PennyStockRumors.net and AllPennyStocks reported on CytoDyn, Inc. (CYDY), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Vancouver, Washington-based CytoDyn, Inc. is a biotechnology company that lists on the OTCQB. The Company is focusing on developing subcutaneously delivered humanized cell-specific monoclonal antibodies (mAbs) as entry inhibitors for the treatment and prevention of Human Immunodeficiency Virus (HIV). CytoDyn has one of the leading mAbs under development for HIV infection - PRO 140. PRO 140 has finished Phase 2 clinical trials with demonstrated antiviral activity in man.
PRO 140 is CytoDyn’s novel self-injectable antibody for the treatment of HIV. PRO 140 is a humanized monoclonal antibody directed against CCR5, a molecular portal that HIV uses to enter cells. PRO 140 belongs to a new class of HIV/AIDS therapeutics - viral-entry inhibitors. The intention of these are to protect healthy cells from viral infection. PRO 140 blocks the HIV co-receptor CCR5. Clinical trial results to date indicate that it does not affect the normal function of the cell.
PRO 140 has been the subject of Phase 1/1b and Phase 2a clinical trials. Results from Phase 1/1b and Phase 2a human clinical trials have shown that PRO 140 can substantially reduce viral burden in people infected with HIV. CytoDyn’s objective is to continue to develop PRO 140 as a therapeutic anti-viral agent in persons infected with HIV.
In addition, PRO 140 has been designated a "fast track" product candidate by the Food and Drug Administration (FDA). The PRO 140 antibody appears to be a strong antiviral agent leading to potentially fewer side effects and less frequent dosing requirements versus daily drug therapies now in use.
CytoDyn has reached an agreement with the FDA on the Company's previously submitted Phase 3 protocol synopsis for PRO 140. Its Phase 3 protocol provides for a 25-week study with 300 HIV patients. CytoDyn’s completed Phase 2b treatment substitution trial demonstrated that 98 percent of all patients treated with PRO 140 successfully passed four weeks of monotherapy without virologic failure. CytoDyn said that Company research data has expanded the potential clinical indications for PRO 140 to include certain inflammatory diseases, autoimmunity, transplantation, and cancer.
Today, CytoDyn announced that its continuing extension study of PRO 140 monotherapy in a cohort of HIV-infected patients has shown complete viral-load suppression for greater than a year with some patients approaching 17 months. Its belief is that complete virologic suppression via treatment with a single agent, PRO 140, a safe and efficacious antibody, rather than through the extensively utilized HAART combination therapy, could present a major opportunity to treat HIV patients. CytoDyn (based on these monotherapy results) plans to file a second Phase 3 protocol for PRO 140 monotherapy with the FDA. Presently, CytoDyn is conducting the pivotal Phase 3 trial for PRO 140 as an adjunct therapy with expected commercialization in 2017.
CytoDyn, Inc. (CYDY), closed Tuesday's trading session at $0.865, up 8.12%, on 217,308 volume with 99 trades. The average volume for the last 60 days is 68,668 and the stock's 52-week low/high is $0.63/$1.09.
Abtech Holdings, Inc. (ABHD)
Greenbackers and Wall Street Resources reported previously on Abtech Holdings, Inc. (ABHD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Abtech Holdings, Inc. is a full-service environmental technologies and engineering firm. The Company provides creative solutions to communities, industry, and governments addressing issues of water pollution and contamination. Abtech provides solutions for Stormwater Management, Oil & Gas Water Treatment, and Industrial Water Treatment. Abtech Holdings’ shares trade on the OTC Markets’ OTCQB. The Company is based in Scottsdale, Arizona. AbTech Industries, Inc. is a subsidiary of Abtech Holdings.
Abtech Holdings integrates its native advanced technologies along with third-party technologies and systems to provide effective and economical solutions to its customers. Abtech commenced marketing of produced water and industrial wastewater treatment, and formed its engineering subsidiary AEWS Engineering in 2012.
AEWS is an independent civil and environmental engineering firm partnered with leading research and engineering universities. The basis of Abtech’s products are on polymer technologies, which can remove hydrocarbons, sediment, and other foreign elements in stormwater runoff, flowing water, and industrial process and wastewater.
Abtech Holdings’ offerings include the antimicrobial technology- Smart Sponge® Plus. This technology is effective in decreasing coliform bacteria found in stormwater, industrial wastewater, as well as municipal wastewater. Smart Sponge® Plus is registered with the Environmental Protection Agency (EPA).
Abtech has deployed and validated onsite its first mobile water pre-treatment system, centered on oil recovery and hydrocarbon removal for the treatment of flowback and produced water for the on-shore Oil & Gas industry. This pre-treatment system integrates its Smart Sponge® technology. The design of it is to operate in advance of other treatment systems, increasing overall efficiency and reducing treatment cost.
This past November, Abtech Holdings reported financial results for its Q3 and nine month periods ended September 30, 2015. Concerning the Company’s key 9-month Year-Over-Year Financial results summary, revenues were approximately the same as the prior year's 9 month revenues at $372,000. Gross profit was also consistent with the prior year 9-month period at roughly $29,000 or 8 percent gross margin.
Abtech’s operating expenses rose by 6.5 percent in the first 9 months of 2015 over the prior year to $4.5 million because of high legal fees. The Company’s operating loss for the 9-month period in 2015 grew 6.6 percent over the same period of the prior year to $4.4 million.
Abtech Holdings, Inc. (ABHD), closed Tuesday's trading session at $0.0275, up 1.85%, on 65,909 volume with 7 trades. The average volume for the last 60 days is 131,651 and the stock's 52-week low/high is $0.009/$0.35.
BFC Financial Corp. (BFCF)
Zacks, OTCPicks, SmallCap Fortunes, and Stock Traders Chat reported previously on BFC Financial Corp. (BFCF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
BFC Financial Corp. is a diversified holding company with its corporate headquarters in Fort Lauderdale, Florida. The Company’s goal is to create long-term value for its shareholders by way of profitable growth of its portfolio companies and appreciation in the value of its investments. Founded in 1980, BFC Financial’s shares trade on the OTC Markets Group’s OTCQB.
BFC Financial’s principal holdings include an 81 percent ownership interest in BBX Capital Corp. (BBX) as well as its indirect ownership interest in Bluegreen Corp. Bluegreen is a wholly-owned subsidiary of Woodbridge Holdings, LLC. BFC Financial owns a 54 percent equity interest in Woodbridge Holdings. BBX Capital owns the remaining 46 percent equity interest in Woodbridge Holdings.
Moreover, BBX Capital Real Estate is a division of BBX Capital. BBX Capital Real Estate specializes in the development, operation, management, and investment in commercial and residential real estate and real estate lending.
BBX Capital involves in the acquisition, ownership and management of joint ventures and investments in real estate and real estate development projects. It also engages in acquisitions, investments and management of middle market operating businesses.
As of September 30, 2015, BBX Capital had total consolidated assets of $390.7 million, shareholders' equity attributable to BBX Capital of $319.6 million, and total consolidated equity of $320.8 million. BBX Capital's book value per share at September 30, 2015 was $19.49.
This month, BBX Capital Real Estate announced it entered into a joint venture (JV) agreement with ContraVest to develop The Addison on Millenia. Case Pomeroy & CO is also an investor in the JV. The Addison on Millenia is situated within BBX Capital Real Estate's 47-acre mixed use development called Gardens on Millenia in Orlando, Florida.
At present, the expectation is that it will consist of ten, two, three and four story buildings with a total of 292 apartment homes. Located on a roughly 11.5-acre parcel, the expectation is that the community will feature a mix of one, two, and three-bedroom apartment homes ranging from 780 to 1,441 square feet.
BFC Financial Corp. (BFCF), closed Tuesday's trading session at $3.00, down 0.99%, on 41,619 volume with 26 trades. The average volume for the last 60 days is 36,340 and the stock's 52-week low/high is $2.75/$3.88.
Acacia Diversified Holdings, Inc. (ACCA)
Real Pennies reported previously on Acacia Diversified Holdings, Inc. (ACCA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A Texas corporation, Acacia Diversified Holdings, Inc.’s intention is to identify and acquire assets or businesses. The Company previously went by the name Acacia Automotive, Inc. It changed its name to Acacia Diversified Holdings, Inc. in October of 2012. Incorporated in 1984, Acacia is based in Florida. The Company’s shares trade on the OTC Markets Group’s OTCQB.
Acacia’s previous focus was the automotive auction arena. This included automobiles, trucks, boats, motor homes, as well as RVs and related. The Company’s emphasis is now changing to give it a broader array of choices for business combinations moving ahead.
Acacia owned automotive auctions from 2007 to 2012 before repositioning itself as a diversified holding company. It entered the citrus food ingredients manufacturing business in 2013, and acquired a truck fleet to service its needs. It sold those assets in June of last year in a buy-out structured by the management of those subsidiaries. In August 2015, Acacia entered into discussions to acquire the MariJ Group of Companies and its management. This acquisition was completed on January 15, 2016.
Today, Acacia Diversified Holdings announced that it acquired the assets and the businesses of MariJ Agricultural, Inc., Canna-Cures R&D, LLC, TropiFlora, LLC, and JR Cannabis Industries, LLC. This is a group of privately held firms in Clearwater, Florida (collectively the MariJ Group). The assets and businesses of the MariJ Group entities will be absorbed into new wholly-owned operating subsidiaries of Acacia Diversified Holdings. The primary thrust will be on its new MariJ Pharmaceuticals, Inc. unit.
Outgoing Acacia Chief Executive Officer, Mr. Steve Sample, said, “Acacia just went from zero to fifty miles per hour in the exciting cannabis pharmaceuticals industry in the blink of an eye. We have been looking for years to find the right fit for our future, and I believe it just happened!”
Acacia Diversified Holdings, Inc. (ACCA), closed Tuesday's trading session at $2.34, up 290.00%, on 104,423 volume with 268 trades. The average volume for the last 60 days is 803 and the stock's 52-week low/high is $0.007/$1.00.
ContentChecked Holdings, Inc. (CNCK)
The QualityStocks Daily Newsletter would like to spotlight ContentChecked Holdings Inc. (CNCK). Today, ContentChecked Holdings Inc. closed trading at $0.60, even for the day. The stock’s average daily volume over the past 60 days is 1,737 and its 52-week low/high is $0.26/$1.99.
ContentChecked Holdings, Inc. the creator of a family of mobile apps for individuals who suffer from food allergies and other dietary needs, today announced that it has released a letter from the Company's CEO, Kris Finstad, to update shareholders on the current status of the Company and important developments.
ContentChecked Holdings Inc. (CNCK) is the parent company of a family of mobile applications designed for individuals with specific dietary requirements. Since the official U.S. launch of its first app in early 2015, ContentChecked has continued to build its database of product information obtained from food manufacturers – the database now incorporates 70% of all conventional U.S. products, fully supporting the needs of ContentChecked customers.
Consumers register their food allergies or intolerances with ContentChecked, and simply scan the bar codes of whichever items they are considering purchasing. The app then provides users with information on what products fit their pre-set requirements. This connection between food producers and users is the basis of the ContentChecked business model – a highly engaged consumer, ready to buy, and in need of recommendations.
By initially focusing upon food allergies and intolerances, ContentChecked had access to a marketplace of more than 15 million people in the United States that suffer from food allergies, in addition to a demographic who develop stomach problems as a result of different foods. Though the overall market for food allergies and intolerances is valued at $13 billion in 2015, ContentChecked further expanded its market reach through the launch of MigraineChecked, SugarChecked and VeganChecked applications.
With these offerings, ContentChecked's market reach now extends to the roughly 38 million people in the United States currently diagnosed with migraines; as well as to the largest health-related cost in the country: the 97 million people at risk of developing, or have already developed, Type 2 diabetes. ContentChecked's growth is spearheaded by a talented team of professionals using their experience in entrepreneurial endeavors, sales, marketing and advisory services, nutrition, web design, social media and graphics and data management to help users better manage their food allergies, migraines, and overall health. Disclaimer
ContentChecked Holdings Inc. Blog
ContentChecked Holdings Inc. News:
Content Checked Holdings CEO Issues Letter to Shareholders on Status of the Company and Future Uplisting Plans
ContentChecked's Examiner.com Debut Provides Healthy, Tasty Holiday Eating Tips
ContentChecked Nutritionist Lends Expertise in ValuePenguin Publication
Avant Diagnostics, Inc. (AVDX)
The QualityStocks Daily Newsletter would like to spotlight Avant Diagnostics, Inc. (AVDX). Today, Avant Diagnostics, Inc. closed trading at $0.25, up 19.05%, on 1,769 volume with 9 trades. The stock’s average daily volume over the past 60 days is 1,333, and its 52-week low/high is $0.20/$1.95.
Amarantus Bioscience Holdings, Inc. today announced that it has entered into a Letter of Intent (the “LOI”) to merge its wholly-owned subsidiary Amarantus Diagnostics into Avant Diagnostics. Under the terms of the agreement, upon execution of definitive agreements, Avant shall issue to Amarantus 80 million shares of common stock of Avant Diagnostics, representing approximately 45% of the combined company’s common stock, and 10 million additional shares of common stock upon achievement of certain sales milestones.
Avant Diagnostics, Inc. (AVDX) is a medical diagnostic technology company that specializes in large panel biomarker screening. The company's first test, OvaDx®, is a sophisticated microarray-based test designed to detect pre-symptomatic ovarian cancer by measuring the activation of the immune system in blood samples in response to early stage ovarian tumor cell development.
In clinical development, OvaDx has indicated high sensitivity and specificity for all types and stages of ovarian cancer, including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous and ovarian adenocarcinoma. Upon FDA approval, Avant plans to offer its diagnostic product as an elective test for women seeking greater wellness, as well as those in the elevated risk category for ovarian cancer.
OvaDx is also expected to be used by doctors to advance the forefront of ovarian cancer treatment, promoting the utilization of improved surgical options and more effective chemotherapies by serving as a supplement to existing tests, such as CA-125, OVA1® and transvaginal ultrasound. In this way, Avant's innovative product will promote earlier diagnoses and, as a result, improved survival rates for patients with ovarian cancer.
As it continues to seek FDA approval for its groundbreaking diagnostic technology, Avant is poised to promote considerable growth in the ovarian cancer market, addressing what is currently the most deadly cancer of the female reproductive system. The company will lean on the industry experience of its management team in order to continue positioning itself for long-term success in the medical diagnostic market. Disclaimer
Avant Diagnostics, Inc. Company Blog
Avant Diagnostics, Inc. News:
Amarantus Enters into Letter of Intent to Merge Diagnostics Business Unit into Avant Diagnostics
Avant Diagnostics to Attend 12th Annual Noble Capital Markets Conference
Avant Diagnostics, Inc. Announces Launch of New Corporate Website
Cherubim Interests, Inc. (CHIT)
The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.0002, up 100.00%, on 360,999,731 volume with 93 trades. The stock’s average daily volume over the past 60 days is 72,133,456, and its 52-week low/high is $0.0001/$0.33.
Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.
The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.
Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.
Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer
Cherubim Interests, Inc. Company Blog
Cherubim Interests, Inc. News:
Cherubim Interests, Inc. Further Bolsters Roster
Cherubim Interests, Inc. Adds Powerhouse VP
Cherubim Interests, Inc. Announces End of Year Convertible Preferred Stock Dividend
Agora Holdings, Inc. (AGHI)
The QualityStocks Daily Newsletter would like to spotlight Agora Holdings, Inc. (AGHI). Today, Agora Holdings, Inc. closed trading at $0.26, up 62.50%, on 330,258 volume with 122 trades. The stock’s average daily volume over the past 60 days is 17,955, and its 52-week low/high is $0.03/$2.50.
Agora Holdings, Inc. (AGHI), together with its wholly-owned subsidiary, Geegle Media, is leading a diversified family entertainment and media enterprise through business segments which include: TV on Demand, interactive media, business products and consumer platforms. With its multi-dimensional approach, Geegle Media supports Agora Holdings' mission to deliver innovate and high-quality business solution products and to deliver video content from around the world.
Geegle Media web platforms include; GeegleTV, Frame, 1000Salads, RealtyTV and LobbyTV. Geegle TV is a multi-platform video entertainment website that curates high-quality video content from around the world. In 2016, GeegleTV will serve as co-producer by airing original content. By exposing undiscovered content to millions of users and rendering it shareable to social media, Geegle TV will serve as a marketing partner to local and internationally based TV shows not yet on the open market.
For commercial use, Geegle Media provides a variety of solutions that include web development and billing software for VoIP applications. RealtyTV is its state-of-the-art platform for real estate brokerages. LobbyTV is another of its widely used products by business offices. For individuals, Geegle TV combines radio, On Demand movies, news, sports and children's content.
Geegle Media is also developing 1000salads, an online hub that encourages healthy lifestyles. The portal will feature recipes and products, health-oriented articles and a curated selection of local restaurants and grocers that deliver to the health-conscious user. Currently in its alpha stage of development, 1000salads is gearing up its sales and marketing in preparation for its launch in 2016.
Geegle Media differs from other On Demand providers, such as Netflix and HBO, in that its service is free of constraints such as subscription, fees and penalties. As consumers increasingly opt for personalized sources of entertainment, Agora recognizes the vast opportunities and growth potential provided by the rising popularity of TV On Demand. The company also benefits from strong and visionary management with a track record of bringing innovative ideas to fruition. Disclaimer
Agora Holdings, Inc. Company Blog
Agora Holdings, Inc. News:
Agora Holdings, Inc. (AGHI) Announces Engagement of QualityStocks Corporate Communications Suite
Agora Holdings, Inc.'s Geegle Media Develops TECH, a Workflow Management Software
Agora Holdings Inc.'s Geegle TV Devising Monetizing Plan for Its Real TV Project
Alternet Systems, Inc. (ALYI)
The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.0149, up 46.08%, on 2,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 111,380, and its 52-week low/high is $0.0055/$0.045.
Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.
Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets
Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.
Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.
With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.
As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer
Alternet Systems, Inc. Company Blog
Alternet Systems, Inc. News:
Alternet Systems (ALYI) CEO Featured in Exclusive QualityStocks Interview
Alternet Payment Solutions Offers Disruptive Omni-Channel Payment Processing Technology in the U.S.
Alternet Systems Appoints Fabio Alvino as CEO of Alternet Payment Solutions
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Agora Holdings, Inc. (AGHI) Announces Engagement of QualityStocks Corporate Communications Suite
- Avant Diagnostics, Inc. (AVDX) Amarantus Enters into Letter of Intent to Merge Diagnostics Business Unit into Avant Diagnostics
- Cherubim Interests, Inc. (CHIT) Further Bolsters Roster
- Dominovas Energy Corp. (DNRG) Signs Financing Agreement With GHS Capital
- Freedom Leaf Inc. (FRLF) Licensing Its Brand for National Growth on the Grass Roots Level
- FlexWeek, Inc. (FXWK) Announces Engagement of QualityStocks Corporate Communications Suite
- Giggles N' Hugs, Inc. (GIGL) Signs Agreement with New York-Based Chardan Capital Markets
- GTX Corp. (GTXO) Launches New Track My Workforce Mobile App and Tracking Portal
- International Stem Cell Corp. (ISCO) Signed a Clinical Service Agreement With the Florey Institute of Neuroscience and Mental Health
- Lingo Media Corp. (LMDCF) Continues to Generate Strong Profits with Q3 Net Income of $631,730
- Moxian, Inc. (MOXC) Covered by Crystal Equity Research
- Nutra Pharma Corp. (NPHC) CEO, Rik J Deitsch, Has Published a Letter to Shareholders Outlining the Current Efforts and the Future Goals of the Company
- Oakridge Global Energy Solutions, Inc. (OGES) Providing Batteries for Unmanned Maritime Vessels
- OurPet's Company (OPCO) Dean Tsengas Named Chief Operations Officer of OurPet's Company
- Star Mountain Resources Inc. (SMRS) Closes Acquisition of Balmat Zinc Mine in New York State